Try our new research platform with insights from 80,000+ expert users

JFrog Xray vs Morphisec comparison

Sponsored
 

Comparison Buyer's Guide

Executive SummaryUpdated on Oct 9, 2024

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

Zafran Security
Sponsored
Ranking in Vulnerability Management
18th
Average Rating
9.4
Reviews Sentiment
8.2
Number of Reviews
5
Ranking in other categories
Continuous Threat Exposure Management (CTEM) (2nd)
JFrog Xray
Ranking in Vulnerability Management
32nd
Average Rating
8.0
Reviews Sentiment
7.1
Number of Reviews
8
Ranking in other categories
Container Security (20th), Software Composition Analysis (SCA) (6th), Software Supply Chain Security (2nd)
Morphisec
Ranking in Vulnerability Management
65th
Average Rating
9.2
Reviews Sentiment
7.4
Number of Reviews
21
Ranking in other categories
Endpoint Protection Platform (EPP) (55th), Advanced Threat Protection (ATP) (35th), Endpoint Detection and Response (EDR) (62nd), Cloud Workload Protection Platforms (CWPP) (33rd), Threat Deception Platforms (16th)
 

Mindshare comparison

As of June 2025, in the Vulnerability Management category, the mindshare of Zafran Security is 0.7%, up from 0.0% compared to the previous year. The mindshare of JFrog Xray is 1.5%, up from 0.5% compared to the previous year. The mindshare of Morphisec is 0.3%, up from 0.1% compared to the previous year. It is calculated based on PeerSpot user engagement data.
Vulnerability Management
 

Featured Reviews

Israel Cavazos Landini - PeerSpot reviewer
Weekly insights and risk analysis facilitate informed security decisions
I appreciate the weekly insights Zafran provides, which include critical topics for networks and IT security, allowing us to evaluate which insights apply to our environment. The organization score feature is valuable to keep the leadership team updated on how our infrastructure fares security-wise. The applicable risk level versus base risk level feature is beneficial because prior to Zafran, we only used the base risk level, but now understand that risk depends on the asset itself. Zafran is an excellent tool.
Mokshi Pandita - PeerSpot reviewer
An intelligent solution that prioritizes which vulnerability to target first in your project
We could create any number of repositories, but we can create only thirty projects with JFrog Xray. If I want things to work, it has to be one project and multiple repositories that belong to different real projects. So I have a limitation of thirty projects, despite being a premium customer. JFrog Xray does not have a dashboard. Although I am able to generate reports, there is no proper dashboard where I can see the total number of vulnerabilities, the total number of license issues, and how many vulnerabilities are fixed. Second, I found the shift left approach missing with JFrog Xray. JFrog Xray has integration with IDEs, but it does not tell you about the vulnerabilities until the artifact is created. However, Snyk could directly integrate with your repository and would not allow you to build unless you fix the problem.
Rick Schibler - PeerSpot reviewer
Offers in-memory protection at a lower price than competitors
Morphisec's in-memory protection is probably the most valuable feature because it stops malicious activity from occurring. If something tries to install or act as a sleeper agent, Morphisec will detect and stop it. Morphisec's Moving Target Defense is critical to hardening our attack surface. If it detects something, it indicates whether it's valid. That means you've got a breach requiring investigation. It detects anomalies but doesn't necessarily point to what caused them. You still need to do that work. The solution is reasonably easy to administer. They made some changes last year, adding a cloud-based monitoring solution that makes deploying and monitoring our endpoints easy.

Quotes from Members

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Pros

"Zafran is an excellent tool."
"Zafran has become an indispensable tool in our cybersecurity arsenal."
"We are able to see the real risk of a vulnerability on our environment with our security tools."
"Overall, we have seen about eighty-seven percent reduction of the number of vulnerabilities that require urgency to remediate, specifically the number of criticals."
"We saw benefits from Zafran Security almost immediately after deploying it."
"The most valuable feature of JFrog Xray is the display of the entire internal dependencies hierarchy."
"JFrog Xray shows us a list of vulnerabilities that can impact our code."
"The most valuable features of JFrog Xray are its curation capabilities, its native integration with Artifactory, scanning for vulnerabilities, and license compliance features."
"JFrog Xray's reporting feature has a lot of options in it, including scanning."
"The most valuable features of JFrog Xray are its curation capabilities, its native integration with Artifactory, scanning for vulnerabilities, and license compliance features."
"The solution is stable and reliable."
"I would say that this solution has helped our organization by allowing us to automate a lot of the processes."
"Good reporting functionalities."
"Morphisec's in-memory protection is probably the most valuable feature because it stops malicious activity from occurring. If something tries to install or act as a sleeper agent, Morphisec will detect and stop it."
"What's valuable is really the whole kit and caboodle of the Morphisec agent. What it does is genius, in a way, until the bad guys get wise to it. You set it up and then you watch the dashboard. There isn't really much tinkering."
"We have seen it successfully block attacks that a traditional antivirus did not pick up."
"The biggest feature is that it hides everything from your operating system that's running in-memory from anything to try to run against it. That's the most unique thing that's on the market. There's nothing else out there that's quite like that. That's a big selling point and why we went with it. It does exactly what the design does. If you can't find it, you can't execute against it."
"It also provides full visibility into security events from Microsoft Defender and Morphisec in one dashboard. We've always had that capability with Morphisec. The more recent version appears to do that even a little bit more natively and it's given us visibility that we didn't have otherwise."
"Morphisec makes it very easy for IT teams of any size to prevent breaches of critical systems because of the design of their tool. When we evaluated Morphisec, the CIO and I sat and listened. What attracted us to them is the fact that it stops activity at the point of detection. That saves a lot of time because now we are not investigating and trying to trace down what to turn off. We have already prevented it, which makes it very much safer and more secure."
"Morphisec makes use of deterministic attack prevention that doesn’t require investigation of security alerts. It changes the memory locations of where certain applications run. If you think of Excel, opening a PDF, running an Excel macro, or opening a webpage and clicking on a link, all of those actions run in a certain area of memory. Morphisec changes the memory locations of where those run."
"Morphisec also provides full visibility into security events for Microsoft Defender and Morphisec in one dashboard... in the single pane of glass provided by Morphisec, it's all right there at your fingertips: easy to access and easy to understand. And if you choose to go down further to know everything from the process to the hash behind it, you can."
 

Cons

"The dashboarding and reporting functionality of Zafran Security is an area that definitely could use some improvements."
"I think the ability to have some enhanced reporting capabilities is something they can improve on, as they have good reports but we have asked for some specific reporting enhancements."
"Initially, we were somewhat concerned about the scalability of Zafran due to our large asset count and the substantial amount of information we needed to process."
"Since we have been using the solution via APIs, there are some limitations in the APIs."
"The speed of JFrog Xray should improve. Other solutions have better performance."
"Reporting is crucial, but it is lacking in the current tool. Every organization seeks specific data points rather than general information. Therefore, we require customized reports from the Xray tool."
"JFrog Xray does not have a dashboard."
"I think that the user interface should be expanded to provide customers with a better dashboard for reviewing their feedback regarding their images and the vulnerabilities that are associated with the images."
"X-ray needs improvement in supporting more than one database, as it currently only supports PostgreSQL."
"The out-of-the-box PostgreSQL provided is not stable, which is why we are considering enterprise support."
"Lacks deeper reporting, the ability to compare things."
"We wanted to have multi-tenants in their cloud platform, so every entity can look into their own systems and not see other systems in other entities. I have a beta version on that now. I would like them to incorporate that in the cloud solution."
"From a company standpoint, a little more interaction with the customers throughout the year might be beneficial. I would like check-ins from the Morphisec account executives about any type of Morphisec news as well as a bit more interaction with customers throughout the year to know if anything new is coming out with Morphisec, e.g., what they are working on in regards to their development roadmap. We tend not to get that up until the time that we go for a yearly renewal. So, we end up talking to people from Morphisec once a year, but it is usually at renewal time."
"We sometimes have to depend on the support team to know what action we should take. If the solution for an alert can be built into the report that we are getting, it will save time, and the interaction with support would be less. At times, corrective action is required, but at times, we don't need to take any action. It would be good if we get to know in the report that a particular infection doesn't require any action. It will save us time and effort."
"Automating reports needs improvement. I would like to have better reporting capabilities within it or automated reporting to be a little bit more dynamic. That's something I know they're working on. We literally are in the process. We started the process a week and a half ago of going to their latest version, so I've not seen their latest one up and running yet."
"If anything, tech support might be their weakest link. The process of getting someone involved sometimes takes a little time. It seems to me that they should have all the data they need to let me know whether an alert is legitimate or not, but they tend to need a lot of information from me to get to the bottom of something. It usually takes a little longer than I would expect."
"Some of the filters for the console need improvement. There are alerts that show up and just being able to acknowledge that we've seen those and not turn them off, but dismiss them, would be a huge benefit."
"We have discovered some bugs in the new releases that they've had to fix, so I would like to see more testing and QA on their side before they release."
"Morphisec is a venture startup. They are still early in their growth stage. They need to get mature on their customer support and on how they interface with system tools. For example, they need to get multifactor in place and an API for the major multi-factor systems, e.g., Okta, Duo, Ping, and Microsoft. They don't have them built in yet. They are working on them. It is just not there yet. Also, their stability, customer support, and processes need improvement, which is just part of maturity."
 

Pricing and Cost Advice

Information not available
Information not available
"We are still using a separate tool. I know for our 600 or I think we're actually licensed for up to 700 users, it runs me 23 or $24,000 a year. When you're talking to that many users plus servers being protected, that's well worth the investment for that dollar amount."
"Our licensing is tied into our contract. Because we have a long-term contract, our pricing is a little bit lower. It is per year, so we don't get charged per endpoint, but we do have a cap. Our cap is 80 endpoints. If we were to go over 80, when we renewed our contract, which is not until three years are over. Then, they would reevaluate, and say, "Well, you have more than 80 devices active right now. This is going to be the price change." They know that we are installing and replacing computers, so the numbers will be all over the place depending on whether you archive or don't archive, which is the reason why we just have to keep up on that stuff."
"It does not have multi-tenants. If South Africa wants to show only the machines that they have, they need their own cloud incidence. It is not possible to have that in a single cloud incidence with multiple tenants in it, instead you need to have multiple cloud incidences. Then, if you have that, it will be more expensive. However, they are going to change that, which is good."
"It is priced correctly for what it does. They end up doing a good deal of discounting, but I think it is priced appropriately."
"Morphisec is reasonably priced because our parent company's other subsidiaries use different products like CrowdStrike. CrowdStrike is four or five times more expensive than Morphisec. The competitive pricing saves us money in our overall security stack."
"It is a little bit more expensive than other security products that we use, but it does provide us good protection. So, it is a trade-off."
"It is an annual subscription basis per device. For the devices that we have in scope right now, it is about $25,000 a year."
"Licenses are per endpoint, and that's true for the cloud version as well. The only difference is that there is a little extra charge for the cloud version."
report
Use our free recommendation engine to learn which Vulnerability Management solutions are best for your needs.
859,438 professionals have used our research since 2012.
 

Top Industries

By visitors reading reviews
Computer Software Company
12%
Financial Services Firm
11%
Manufacturing Company
7%
Healthcare Company
6%
Financial Services Firm
25%
Computer Software Company
12%
Manufacturing Company
11%
Government
5%
Outsourcing Company
15%
Computer Software Company
13%
Financial Services Firm
11%
Manufacturing Company
8%
 

Company Size

By reviewers
Large Enterprise
Midsize Enterprise
Small Business
No data available
 

Questions from the Community

What is your experience regarding pricing and costs for Zafran Security?
The current pricing of Zafran Security is fair overall. They were good to work with to accommodate our organization w...
What needs improvement with Zafran Security?
The dashboarding and reporting functionality of Zafran Security is an area that definitely could use some improvement...
What is your primary use case for Zafran Security?
Zafran Security is helping reduce the amount of critical vulnerabilities in our environments that require prompt reme...
What do you like most about JFrog Xray?
JFrog Xray shows us a list of vulnerabilities that can impact our code.
What needs improvement with JFrog Xray?
X-ray needs improvement in supporting more than one database, as it currently only supports PostgreSQL. More support ...
What is your primary use case for JFrog Xray?
Our primary use case for X-ray includes multiple activities such as security and vulnerability scanning. We already u...
Ask a question
Earn 20 points
 

Also Known As

No data available
JFrog Security Essentials
Morphisec, Morphisec Moving Target Defense
 

Overview

 

Sample Customers

Information Not Available
google, amazon, cisco, netflix, oracle, vmware, facebook
Lenovo/Motorola, TruGreen, Covenant Health, Citizens Medical Center
Find out what your peers are saying about JFrog Xray vs. Morphisec and other solutions. Updated: June 2025.
859,438 professionals have used our research since 2012.